MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...

Hologic is putting down about $310 million to acquire Endomagnetics, the developer of technologies for localizing tumors in breast cancer surgeries without using radioactive materials. Also known as ...

Hologic Inc. moved to expand its breast surgery line with the acquisition of Endomagnetics Ltd. (Endomag) for a proposed $310 million. Endomag offers a magnetic system that allows precise localization ...

Hologic, Inc. HOLX announced that it has completed the previously announced acquisition of Endomagnetics Limited (Endomag), a UK-based developer of breast cancer surgery technologies, for ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Leader in Women’s Health Will Unveil Groundbreaking Innovations With a Focus on Imaging Solutions and Artificial Intelligence Experience the cutting-edge Envision™ Mammography Platform (Graphic: ...

Hologic HOLX is a long-standing innovator in developing and advancing technologies to help detect and treat breast cancer. The Massachusetts-based MedTech firm rang the Nasdaq opening bell for the ...